Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Efferth

Showing results (21-30 of 821) with videos related to

Pageof 83
Sort By:
Biotechnology Advances|January 7, 2018
Beyond malaria: The inhibition of viruses by artemisinin-type compoundsThomas Efferth
Journal of Ethnopharmacology|July 19, 2011
Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapyVictor Kuete, Thomas Efferth
Frontiers in Pharmacology|August 12, 2011
Cameroonian medicinal plants: pharmacology and derived natural productsVictor Kuete, Thomas Efferth
Molecular Medicine Reports|April 12, 2011
Human cytomegalovirus: Drug resistance and new treatment options using natural productsSilviya Stoeva, Thomas Efferth
Current Neuropharmacology|November 12, 2016
Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress DisorderJanine Naß, Thomas Efferth
Investigational New Drugs|March 18, 2014
Contributions from emerging transcriptomics technologies and computational strategies for drug discoveryOnat Kadioglu, Thomas Efferth
In Vivo (Athens, Greece)|March 31, 2005
Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunateThomas Efferth, Manfred Volm
Experimental Hematology & Oncology|December 12, 2012
Polo-like kinase 1 as target for cancer therapyLily Weiß, Thomas Efferth
Pharmacological Research|May 18, 2019
Development of artemisinin resistance in malaria therapyJanine Naß, Thomas Efferth
Biochemical Pharmacology|January 12, 2020
Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics)Nadire Özenver, Thomas Efferth
Pageof 83

Showing results (21-30 of 821) with videos related to

Sort By:
Pageof 83
Biotechnology Advances|January 7, 2018
Beyond malaria: The inhibition of viruses by artemisinin-type compoundsThomas Efferth
Journal of Ethnopharmacology|July 19, 2011
Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapyVictor Kuete, Thomas Efferth
Frontiers in Pharmacology|August 12, 2011
Cameroonian medicinal plants: pharmacology and derived natural productsVictor Kuete, Thomas Efferth
Molecular Medicine Reports|April 12, 2011
Human cytomegalovirus: Drug resistance and new treatment options using natural productsSilviya Stoeva, Thomas Efferth
Current Neuropharmacology|November 12, 2016
Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress DisorderJanine Naß, Thomas Efferth
Investigational New Drugs|March 18, 2014
Contributions from emerging transcriptomics technologies and computational strategies for drug discoveryOnat Kadioglu, Thomas Efferth
In Vivo (Athens, Greece)|March 31, 2005
Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunateThomas Efferth, Manfred Volm
Experimental Hematology & Oncology|December 12, 2012
Polo-like kinase 1 as target for cancer therapyLily Weiß, Thomas Efferth
Pharmacological Research|May 18, 2019
Development of artemisinin resistance in malaria therapyJanine Naß, Thomas Efferth
Biochemical Pharmacology|January 12, 2020
Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics)Nadire Özenver, Thomas Efferth
Pageof 83